NaturesPlus Testosterone Supplement Recalled for Missing Ingredient and Incorrect Formulation
Natural Organics is recalling NaturesPlus ULTRA T-MALE due to incorrect formulation: the product is missing the ingredient TongKat Ali and contains additional Rhodiola Rosea. No illnesses have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall—the lowest-risk category—involving a formulation error with no reported illnesses or injuries. The hazard is labeling-based rather than related to documented harm.
Plain-English summary
Natural Organics, Inc. is recalling NaturesPlus ULTRA T-MALE Maximum Strength Testosterone Boost for Men 60 Bi-layer Tablets due to an ingredient formulation error. The product is missing the ingredient TongKat Ali and contains additional Rhodiola Rosea.
The recall affects 11,496 bottles distributed in the United States as well as internationally to Germany, Trinidad, Bermuda, Africa, Greece, and Panama. The affected lots are 1381667 and 1381994, both with a best-by date of 03/2028. The product UPC code is 0 97467 48716 1 and product number is 48716.
Consumers who have purchased this product should stop using it. Those with questions should contact the manufacturer or their healthcare provider.
The recalled product
- Product
- NaturesPlus ULTRA T-MALE Maximum Strength Testosterone Boost for Men 60 Bi-layer Tablets
- Manufacturer
- Natural Organics, Inc.
- Category
- Drug — Dietary Supplement
- Hazard
- mis-labeling
- formulation-error
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27